AGIOS PHARMACEUTICALS, INC. Logo

AGIOS PHARMACEUTICALS, INC.

Biopharmaceutical company developing therapies for rare and genetically defined diseases.

AGIO | US

Overview

Corporate Details

ISIN(s):
US00847X1046
LEI:
Country:
United States of America
Address:
88 SIDNEY STREET, 2139 CAMBRIDGE

Description

Agios Pharmaceuticals is a commercial-stage biopharmaceutical company that develops therapies for rare and genetically defined diseases. The company leverages its expertise in the science of cellular metabolism to discover and advance new treatments. Its near-term therapeutic focus is on hemolytic and acquired anemias. The company's lead medicine is PYRUKYND® (mitapivat), a first-in-class pyruvate kinase activator. Agios aims to establish a portfolio of disease-modifying therapies that provide long-term effects for patients with significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-07 17:23
FORM 4
English ZIP 7.7 KB
2026-01-05 22:05 English ZIP 7.0 KB
2026-01-03 02:18
FORM 4
English ZIP 7.9 KB
2026-01-03 02:16
FORM 4
English ZIP 8.3 KB
2026-01-03 02:15
FORM 4
English ZIP 7.9 KB
2026-01-03 02:15
FORM 4
English ZIP 8.0 KB
2026-01-03 02:14
FORM 4
English ZIP 8.1 KB
2025-12-30 22:20 English ZIP 6.8 KB
2025-12-30 22:18 English ZIP 7.1 KB
2025-12-30 22:16 English ZIP 6.8 KB
2025-12-30 22:13 English ZIP 6.8 KB
2025-12-30 22:11 English ZIP 6.8 KB
2025-12-05 23:42 English ZIP 8.8 KB
2025-11-14 22:34 English ZIP 9.8 KB
2025-11-14 22:04
FORM 4
English ZIP 7.1 KB

Automate Your Workflow. Get a real-time feed of all AGIOS PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AGIOS PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AGIOS PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.